Loading…
TELA Bio, Inc. is projected to decline to $0.7583 by 2027, a -13% move from its current price of $0.869. TELA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $0.8162 | $0.8681 | $0.9234 | -0.10% |
| May 30 | $0.7948 | $0.8673 | $0.9464 | -0.20% |
| May 31 | $0.7785 | $0.8664 | $0.9643 | -0.29% |
| Jun 1 | $0.765 | $0.8656 | $0.9794 | -0.39% |
| Jun 2 | $0.7532 | $0.8647 | $0.9928 | -0.49% |
| Jun 3 | $0.7426 | $0.8639 | $1.00 | -0.59% |
| Jun 4 | $0.7329 | $0.863 | $1.02 | -0.69% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.7329 | $0.863 | $1.02 | -0.69% |
| Week 2 | $0.6803 | $0.8571 | $1.08 | -1.37% |
| Week 3 | $0.6414 | $0.8512 | $1.13 | -2.05% |
| Week 4 | $0.6097 | $0.8454 | $1.17 | -2.72% |
| Week 5 | $0.5826 | $0.8396 | $1.21 | -3.39% |
| Week 6 | $0.5588 | $0.8338 | $1.24 | -4.05% |
| Week 7 | $0.5374 | $0.8281 | $1.28 | -4.71% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
TELA Bio, Inc. is a commercial-stage medical technology company focused on soft-tissue reconstruction solutions that prioritize preserving and restoring the patient’s anatomy. Its portfolio includes OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction, as well as OviTex PRS Reinforced Tissue Matrix products for plastic and reconstructive surgery.
The company also offers OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene, polyglycolic acid, and polylactic-co-glycolic acid. The company markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc.
was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
TELA Bio, Inc. trades at $0.8901 per share and has a market cap of $39.85M. The company is ranked 4695 in market capitalization. Near-term forecasts place the stock around the current price, with a 2026 min of $0.56, an avg of $0.8901, and a max of $1.29, while the 30-day price range spans from $0.594 to $1.33.
The long-run outlook shows meaningful upside, with 2030–2050 forecasts highlighting bullish momentum and substantial ROI potential, including a 2050 average of $3.00 and a max of $6.91.
A major floor 58.2% below — a decisive break under it would weaken the trend.
The nearest floor, 28.7% below — buyers have tended to step in here.
The nearest ceiling, 30.0% above — a clean break opens room to run.
A major ceiling 59.1% above — clearing it would confirm fresh momentum.
Key TELA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of TELA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.889 | Sell | $0.8745 | Sell |
| MA 10 | $0.899 | Sell | $0.8953 | Sell |
| MA 20 | $0.9517 | Sell | $0.8905 | Sell |
| MA 50 | $0.7847 | Buy | $0.85 | Buy |
| MA 100 | $0.8426 | Buy | $0.9015 | Sell |
| MA 200 | $1.12 | Sell | $1.14 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 49.57 | Neutral |
| Stoch RSI (14) | 16.97 | Buy |
| CCI (20) | -74.30 | Neutral |
| Williams %R (14) | -80.77 | Info |
| MACD (12,26,9) | -0.02 | Sell |
| ROC (12) | -14.80 | Sell |
| Bollinger %B (20,2) | 0.27 | Neutral |
| Stochastic %K (14) | 19.23 | Buy |
| TRIX (15) | 0.89 | Buy |
| Awesome (5,34) | 0.06 | Buy |
| Ultimate (7,14,28) | 45.87 | Neutral |
| Momentum (10) | -0.15 | Sell |
| Aroon Osc (25) | 40.00 | Buy |
| Hull MA (9) | 0.86 | Buy |
| ADX (14) | 13.64 | Neutral |
| ATR (14) | 0.06 | Info |
The 30-day technical picture is mixed but balanced, with neutral sentiment and a current RSI of 50. The moving averages place price around the mid-range: SMA50 at $0.7805 and SMA200 at $1.13. The stock’s defined 30-day range runs from $0.594 to $1.33, indicating a modest upside potential within the near term.
Support is identified at $0.56 and resistance at $1.13, suggesting any moves will likely respect these levels in the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.56 | $0.869 | $1.26 | 0% | Neutral | |
| $0.5457 | $0.7583 | $1.14 | -13% | Neutral | |
| $0.5079 | $0.749 | $1.20 | -14% | Neutral | |
| $0.5357 | $0.8316 | $1.39 | -4% | Neutral | |
| $0.6066 | $0.9866 | $1.72 | +14% | Neutral | |
| $0.7846 | $1.33 | $2.40 | +53% | Bullish | |
| $0.7353 | $1.30 | $2.42 | +50% | Bullish | |
| $0.6394 | $1.18 | $2.25 | +36% | Bullish | |
| $0.6643 | $1.28 | $2.50 | +47% | Bullish | |
| $0.5889 | $1.17 | $2.35 | +35% | Bullish | |
| $0.8197 | $1.82 | $4.01 | +110% | Bullish | |
| $1.39 | $3.10 | $7.13 | +257% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.56 | $0.869 | $1.03 | +0.00% |
| June 2026 | $0.6783 | $0.8134 | $1.01 | -6.40% |
| July 2026 | $0.6513 | $0.7944 | $1.01 | -2.34% |
| August 2026 | $0.6787 | $0.8388 | $1.09 | +5.60% |
| September 2026 | $0.67 | $0.8373 | $1.10 | -0.18% |
| October 2026 | $0.6429 | $0.8117 | $1.09 | -3.06% |
| November 2026 | $0.676 | $0.8613 | $1.17 | +6.12% |
| December 2026 | $0.7165 | $0.9209 | $1.26 | +6.91% |
Click any year to see its month-by-month TELA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
TELA Bio, Inc.'s 2026 outlook centres on $0.869, within a $0.56 to $1.26 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, TELA could reach as high as $1.14, with a base case around $0.7583 and support toward $0.5457 — roughly -13% from $0.869. Price action looks broadly range-bound.
Expect TELA to range from $0.5079 to $1.20 through 2028. The $0.749 average target implies a -14% move from current prices. That is -1% versus the projected 2027 average. A consolidation phase looks the most probable path here.
The TELA price prediction for 2029 points to an average of $0.8316 (low $0.5357, high $1.39) — a potential decline of -4% on today's $0.869. Price action looks broadly range-bound.
In 2030, TELA is projected to trade between $0.6066 and $1.72, averaging $0.9866 — a potential gain of +14% from today's $0.869. That is up +19% on the projected 2029 average. A consolidation phase looks the most probable path here.
TELA Bio, Inc.'s 2031 outlook centres on $1.33, within a $0.7846 to $2.40 range. That is up +35% on the projected 2030 average. That marks a +53% change versus current levels. Momentum favours further upside here.
By 2032, TELA could reach as high as $2.42, with a base case around $1.30 and support toward $0.7353 — roughly +50% from $0.869. Buyers look set to stay in control over this stretch.
Expect TELA to range from $0.6394 to $2.25 through 2033. The $1.18 average target implies a +36% move from current prices. That is -9% versus the projected 2032 average. Momentum favours further upside here.
The TELA price prediction for 2034 points to an average of $1.28 (low $0.6643, high $2.50) — a potential gain of +47% on today's $0.869. Buyers look set to stay in control over this stretch.
In 2035, TELA is projected to trade between $0.5889 and $2.35, averaging $1.17 — a potential gain of +35% from today's $0.869. That is -8% versus the projected 2034 average. Momentum favours further upside here.
TELA Bio, Inc.'s 2040 outlook centres on $1.82, within a $0.8197 to $4.01 range. That is up +55% on the projected 2035 average. That marks a +110% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, TELA could reach as high as $7.13, with a base case around $3.10 and support toward $1.39 — roughly +257% from $0.869. Momentum favours further upside here.
Investing $1,000 in TELA today (≈ 1,150.747986 TELA) could be worth
$3,567.04
+$2,567.04 (+257%) by 2050 · US Dollar
Based on the average projected TELA price of $3.1 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in TELAwould be worth at today's price.
$1,000 invested in TELA on May 27, 2025 (≈ 675.675667 TELA) would be worth
$587.16
-$412.84 (-41.3%) today · 0.59× · US Dollar
Based on a TELA entry price of $1.48 vs. today's $0.869.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.949 | $915.7 | -8.4% |
| 1 month ago | $0.8 | $1,086.25 | +8.6% |
| 3 months ago | $0.818 | $1,062.35 | +6.2% |
| 6 months ago | $1.15 | $755.65 | -24.4% |
| 1 year ago | $1.48 | $587.16 | -41.3% |
| All time (5.0y) ago | $13.24 | $65.63 | -93.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our TELA forecast.
Our base-case forecast reaches $1.70 around 2040.
Implied market cap at $1.70: $76.1M
The multi-year forecast shows a gradual drift higher starting in 2030, with 2030 averaging $0.9734 and a max of $1.70, yielding a 9.4% ROI. The outlook strengthens into 2031 and 2032, with 2031 averaging $1.34 and a max of $2.41 (ROI 50.1%), and 2032 averaging $1.29 (ROI 45.4%). The forecast continues to be bullish through the decade, with 2040 averaging $1.81 and a max of $3.98 (ROI 103.4%).
The long-term view culminates in 2050, with an average of $3.00 and a max of $6.91 (ROI 237.4%), signaling substantial upside potential over the horizon. Near-term years 2026–2029 show more muted performance, with 2026 averaging $0.8901 (ROI 0) and 2027–2029 posting negative ROIs of -14.3%, -14.4%, and -6.3% respectively, reflecting near-term volatility before the longer-term upside materializes. While the numbers indicate meaningful upside over the extended horizon, these are forecasts and not guarantees, and uncertainty remains.
Tap a question to reveal the answer.
The 2030 forecast shows a min of $0.5981, an avg of $0.9734, and a max of $1.70, with a ROI of 9.4% and neutral sentiment.
The near-term outlook (2026–2029) is neutral to negative in some years, but the long-term view turns bullish from 2031 onward, with the 2050 forecast average of $3.00 and a max of $6.91 and ROI of 237.4%.
Yes. The forecast maximums include $2.41 in 2031 and 2032, $2.52 in 2034, $3.98 in 2040, and $6.91 in 2050, while the 2030 max is $1.70.
Current price is $0.8901, market cap is $39.85M, and the rank is 4695.
The sentiment is NEUTRAL with RSI(14) at 50. The SMA(50) is $0.7805 and SMA(200) is $1.13. The 30-day range is $0.594 to $1.33, with a support at $0.56 and resistance at $1.13.
TELA Bio, Inc. Community Discussion
0Share your TELA Bio, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.